Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma

Journal of Clinical Pathology

Volumn 58, Issue 10, 2005, Pages 1069-1075

  Rocken C ^a   Licht, J ^a   Roessner, A ^a   Carl McGrath, S ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTIBODY; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIGENS, CD; ANTIGENS, CD13; BILE CANALICULI; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEPRILYSIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 26244443837     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.026328     Document Type: Article

References (38)

1. D'Errico A, Baccarini P, Fiorentino, M, et al. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 1996;27:599-604.
2. Hurlimann J, Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am J Surg Pathol 1991;15:280-8.
3. Ma CK, Zarbo RJ, Frierson HF Jr, et al. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 1993;99:551-7.
4. Koelma IA, Nap M, Huitema S, et al. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 1986;110:1035-40.
5. Wong MA, Yazdi HM. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material. Acta Cytol 1990;34:192-6.
6. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-92.
7. Oliveira AM, Erickson LA, Burgart LJ, et al. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA. Am J Surg Pathol 2000;24:177-82.
8. Christensen WN, Boitnott JK, Kuhajda FP. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. Mod Pathol 1989;2:8-12.
9. Borscheri N, Roessner A, Röcken C. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol 2001;25:1297-303.
10. Saad RS, Luckasevic TM, Noga CM, et al. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Diagn Cytopathol 2004;30:1-6.
11. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-88.
12. Morrison C, Marsh W Jr. Frankel WL. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002;15:1279-87.
13. Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002;33:1175-81.
14. Fu X, Tan L, Liu S, et al. A novel diagnostic marker, p28(GANK), distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol 2004;130:514-20.
15. Lee HS, Kim WH, Kang GH. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, ana non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker. J Korean Med Sci 2003;18:842-8.
16. Siddiqui MT, Saboorian MH, Gokaslan ST, et al. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52.
17. Murray GI, Paterson PJ, Ewen SW, et al. In situ hybridisation of albumin mRNA in normal liver and hepatocellular carcinoma with a digoxigenin labelled oligonucleotide probe. J Clin Pathol 1992;45:21-4.
18. Yamaguchi K, Nalesnik MA, Carr BI. In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:361-5.
19. Krishna M, Lloyd RV, Batts KP. Detection of albumin messenger RNA in hepatic and extrahepatic neoplasms. A marker of hepatocellular differentiation. Am J Surg Pathol 1997;21:147-52.
20. Papotti M, Pacchioni D, Negro F, et al. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Mod Pathol 1994;7:271-5.
21. Ganjei P, Nadji M, Albores-Saavedra J, et al. Histologic markers in primary and metastatic tumors of the liver. Cancer 1988;62:1994-8.
22. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993;13:113-22.
23. Röcken C, Carl-McGrath S, Gräntzdörffer I, et al. Ectopeptidases are differentially expressed in hepatocellular carcinomas. Int J Oncol 2004;24:487-95.
24. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
25. MacSween RNM, Burt AD, Portmann BC, et al. Pathology of the liver. Edinburgh: Churchill Livingstone, 2002.
26. Mechtersheimer G, Moller P. Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol 1990;137:1215-22.
27. Takuhara T, Adachi M, Hashida H, et al. Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 2001;49:489-96.
28. Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993;54:137-43.
29. Menrad A, Speicher D, Wacker J, et al. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 1993;53:1450-5.
30. Kido A, Krueger S, Haeckel C, et al. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin Exp Metastasis 1999;17:857-63.
31. Hashida H, Takabayashi A, Kanai M, et al. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 2002;122:376-86.
32. Ishii K, Usui S, Sugimura Y, et al. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull 2001;24:226-30.
33. Lian WN, Tsai JW, Yu PM, et al. Targeting of aminopeptidase N to bile canaliculi correlates with secretory activities of the developing canalicular domain. Hepatology 1999;30:748-60.
34. Bartles JR, Zhang LQ, Verheyen EM, et al. Decreases in the relative concentrations of specific hepatocyte plasma membrane proteins during liver regeneration: down-regulation or dilution? Dev Biol 1991;143:258-70.
35. Lin F, Abdallah H, Meschter S. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Diagn Cytopathol 2004;30:92-7.
36. Xiao SY, Wang HL, Hart J, et al. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 2001;159:1415-21.
37. Leong AS, Sormunen RT, Tsui WM, et al. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998;33:318-24.
38. Fan Z, van de Rijn M, Montgomery K, et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-44.